Clinical trial
Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer
NCT00005655 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00005655 |
|---|---|
| Title | Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer |
| Official title | A Phase I Investigation of IL-12/Pulse IL-2 in Adults With Advanced Solid Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Kidney Neoplasm, Lung Neoplasm, Sarcoma, Breast Neoplasm |
| Intervention type | Biological |
| Interventions | rh IL-12, rh IL-2 |
| Enrollment | 39 |
| Start date | Apr 28, 2000 |
| Primary completion | Oct 6, 2010 |
| Completion | Mar 2, 2017 |
| First posted | May 5, 2000 |
| Last update posted | Dec 17, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: